These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6755590)

  • 1. Glucose-induced hyperkalemia developing in the upright position in captopril-treated hypertensives.
    Radó JP; Bános C; Gercsák G; Molnár Z; Pató E; Csabuda M
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):161-4. PubMed ID: 6755590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of various factors in glucose-induced hyperkalemia during captopril treatment.
    Radó JP; Gercsák G; Bános C
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):69-76. PubMed ID: 3514489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of hyperkalemia associated with prolonged treatment with captopril by glucose-induced acute serum potassium changes.
    Radó JP
    Exp Clin Endocrinol; 1984 Oct; 84(2):143-7. PubMed ID: 6396097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of glucose-induced hyperkalemia by sodium restriction in "normaldosteronemic" diabetes mellitus.
    Radó JP
    Endokrinologie; 1981 Dec; 78(2-3):244-52. PubMed ID: 7037374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of hyperkalemia in systemic lupus erythematosus.
    Lee FO; Quismorio FP; Troum OM; Anderson PW; Do YS; Hsueh WA
    Arch Intern Med; 1988 Feb; 148(2):397-401. PubMed ID: 3277563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative effects of captopril and chlorthalidone on glucose tolerance and insulin levels essential hypertensives].
    Zanella MT; Baptista M; Costa CH; Kohlmann NE; Kohlmann Júnior O; Ribeiro AB
    Arq Bras Cardiol; 1996 Jul; 67(1):47-52. PubMed ID: 9035467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-induced hyperkalemia in diabetic subjects.
    Nicolis GL; Kahn T; Sanchez A; Gabrilove JL
    Arch Intern Med; 1981 Jan; 141(1):49-53. PubMed ID: 7447584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of glucose-induced hyperkalemia by sodium restriction in normaldosteronemic diabetes: evidence for elevated mineralocorticoid threshold.
    Rado JP
    Biomedicine; 1981 Sep; 35(4):109-11. PubMed ID: 7295860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Outpatient hyperkalemia" syndrome in renal and hypertensive patients with suppressed aldosterone production.
    Rado JP; Boer P; Dorhout Mees EJ; Simatupang T
    J Med; 1979; 10(3):145-57. PubMed ID: 289714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose induced paradoxical serum potassium elevation exclusively in the upright posture in metoprolol treated hypertensives.
    Radó JP
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):159-60. PubMed ID: 6505387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia.
    Burnakis TG; Mioduch HJ
    Arch Intern Med; 1984 Dec; 144(12):2371-2. PubMed ID: 6391404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deterioration of renal function and hyperkalemia in hypertensive patients with impaired renal function during captopril administration.
    Kodama K; Morotomi Y; Kida O; Higa T; Someya N; Kondo K; Tanaka K
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):327-35. PubMed ID: 3894730
    [No Abstract]   [Full Text] [Related]  

  • 13. Postural plasma aldosterone response in "upright hyperkalemia" associated with selective hypoaldosteronism.
    Rado JP; Simatupang T; Boer P; Dorhout Mees EJ
    Biomedicine; 1977 Jul; 27(6):209-11. PubMed ID: 907798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of posture and a mineralocorticoid on the glucose-induced hypokalemia in man.
    Radó JP; Gercsák GY; Bános CS
    Biomed Pharmacother; 1984; 38(4):212-3. PubMed ID: 6388654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-induced hyperkalemia during captopril treatment.
    Radó JP
    Arch Intern Med; 1983 Feb; 143(2):389. PubMed ID: 6337577
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucose-induced hyperkalemia in normaldosteronemic diabetes associated with hyperthyroidism.
    Radó JP
    Endokrinologie; 1981 Dec; 78(2-3):239-43. PubMed ID: 7037373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperkalemia and hyperglycemic increments in plasma potassium in diabetes mellitus.
    Popp D; Achtenberg JF; Cryer PE
    Arch Intern Med; 1980 Dec; 140(12):1617-21. PubMed ID: 7006540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperkalemia resulting from captopril administration.
    Warren SE; O'Connor DT
    JAMA; 1980 Dec; 244(22):2551-2. PubMed ID: 7001073
    [No Abstract]   [Full Text] [Related]  

  • 20. A possible role for human growth hormone (HGH) in the protection from glucose-induced hyperkalemia in normaldosteronemic diabetes.
    Radó JP
    Endokrinologie; 1982 Nov; 80(3):364-6. PubMed ID: 7166165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.